Our results indicated that XAV939 reversed the effect of ACTR2 overexpression on the carcinogenesis of DLBCL, suggesting ACTR2 acted as an oncogene in DLBCL by triggering canonical Wnt pathway. Here, ACTR2 is linked to diffuse large B-cell lymphoma.